News & Articles

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

Companies team-up to promote the use of protein footprinting technologies, products, and contract research services in biopharmaceutical research and development

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

30 stories from customers, partners and employees celebrate the past and look ahead to joint success in the future

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London

The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford

Undetectable levels of DNase and RNase in purified water

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

Company exploring further additional global capacity to provide broad and equitable access

Diagnostics for glycemic monitoring and ketosis testing on show

Results from prospective trials show a “clear prognostic value” for CTC counts

Thermo Scientific software suite expands capabilities in sample analysis with enhanced flexibility, reliability and customization

Participation will help advance liquid biopsy adoption by collaborating among key industry stakeholders

Sciencescope becomes Autoscribe's Sub-Saharan Africa distributor

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

Certification affirms commitment to providing the highest standards of quality and customer service

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations